{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:10:09Z","timestamp":1785175809373,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["#2022YFC2705003"],"award-info":[{"award-number":["#2022YFC2705003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: The detection of mutations from circulating tumor DNA (ctDNA) represents a promising enrichment technique. In this retrospective study, the significance of ctDNA and imaging in Langerhans cell histiocytosis (LCH) monitoring was first examined, and the broader role of ctDNA in monitoring LCH was additionally explored. Methods: First, data visualization and survival analysis models were used to generalize the concordance between cfBRAFV600E molecular response and radiographic response on clinical outcomes. Next, the molecular response of cfBRAFV600E was observed from a dynamic perspective. A comparative analysis was then conducted between cfBRAFV600E and ltBRAFV600E status, examining their relationship to clinical manifestations and prognosis of LCH. Results: Eventually, 119 participants were enrolled in this trial between 2019 and 2023. Progression-free survival (PFS) was significantly shorter in patients with both radiologic and cfDNA molecular progression (17.67 versus 24.67 months, p &lt; 0.05) compared to those without. A critical cfBRAFV600E value of 0.03% has been determined for the first time. Both cfBRAFV600E and ltBRAFV600E mutations were associated with a higher proportion of children under 3 years of age, skin and spleen involvement, and a lower 3-year PFS rate. In contrast to ltBRAFV600E, cfBRAFV600E was linked to a higher proportion of risk organ invasion LCH (52% vs. 27.9%, p &lt; 0.05) and a better therapeutic response at the sixth week (24% vs. 4.7%, p &lt; 0.05). Furthermore, in patients with risk organ invasion-LCH and multisystem-LCH subtypes, cfBRAFV600E was associated with a significantly lower 3-year PFS. Conclusions: In summary, these findings enhanced and supplemented the implications of ctDNA and imaging analysis application in children with LCH.<\/jats:p>","DOI":"10.3390\/children11121449","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:26:08Z","timestamp":1732706768000},"page":"1449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circulating Tumor DNA Combining with Imaging Analysis for Lesion Detection of Langerhans Cell Histiocytosis in Children"],"prefix":"10.3390","volume":"11","author":[{"given":"Siying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-Cell Histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"2422","article-title":"Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells","volume":"108","author":"Hagey","year":"2023","journal-title":"Haematologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1007\/s10238-023-01134-w","article-title":"Somatic ARAF mutations in pediatric Langerhans cell histiocytosis: Clinicopathologic, genetic and functional profiling","volume":"23","author":"Liu","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2017.05.059","article-title":"Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis","volume":"78","author":"Krooks","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/apa.16014","article-title":"Clinical features and treatment of Langerhans cell histiocytosis","volume":"110","year":"2021","journal-title":"Acta Paediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.2021014343","article-title":"International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults","volume":"139","author":"Goyal","year":"2022","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41591-021-01304-x","article-title":"BRAF(V600E)-induced senescence drives Langerhans cell histiocytosis pathophysiology","volume":"27","author":"Bigenwald","year":"2021","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/neuonc\/noab107","article-title":"Histiocytosis and the nervous system: From diagnosis to targeted therapies","volume":"23","author":"Idbaih","year":"2021","journal-title":"Neuro Oncol."},{"key":"ref_9","first-page":"1137","article-title":"Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders","volume":"109","author":"Cournoyer","year":"2023","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, J.R., Yoon, H.M., Jung, A.Y., Cho, Y.A., Seo, J.J., and Lee, J.S. (2019). Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans Cell Histiocytosis. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-36501-1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hon.2857","article-title":"Langerhans cell histiocytosis: Version 2021","volume":"39","author":"Gulati","year":"2021","journal-title":"Hematol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Thalhammer, J., Jeziorski, E., Marec-Berard, P., Barkaoui, M.A., Pagnier, A., Rohrlich, P.S., Chevallier, A., Carausu, L., Aladjidi, N., and Rigaud, C. (2024). Childhood Langerhans cell histiocytosis hematological involvement: Severity associated with BRAFV600E loads. Blood, Online ahead of print.","DOI":"10.1182\/blood.2024025625"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12964-022-00917-0","article-title":"Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis","volume":"20","author":"Gao","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sconocchia, T., Fo\u00dfelteder, J., Sconocchia, G., and Reinisch, A. (2023). Langerhans cell histiocytosis: Current advances in molecular pathogenesis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1275085"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lang, M., Chang, L., Cai, H., Lin, H., Liu, Z.Z., Duan, M.H., Zhou, D.B., and Cao, X.X. (2024). BRAF deletion in adult patients with Langerhans cell histiocytosis correlates with multisystem disease and poor outcome. Clin. Cancer Res., Online ahead of print.","DOI":"10.2139\/ssrn.4742796"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.arbres.2022.02.015","article-title":"The MAPK Pathway in Pulmonary Langerhans Cell Histiocytosis","volume":"59","author":"Jouenne","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ji, H., Long, X., Gu, J., Jin, J., Mao, X., Wang, Z., Ma, H., and Chen, L. (2021). Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series. Diagnostics, 11.","DOI":"10.3390\/diagnostics11112055"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41375-021-01439-3","article-title":"Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis","volume":"36","author":"Chen","year":"2022","journal-title":"Leukemia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00432-021-03810-4","article-title":"Clinical study of MAP2K1-mutated Langerhans cell histiocytosis in children","volume":"148","author":"Yang","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-022-01526-8","article-title":"Proteomics technologies for cancer liquid biopsies","volume":"21","author":"Ding","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: Current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2022.03.036","article-title":"Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients","volume":"172","author":"Bagnasco","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14695","article-title":"Circulating cell-free BRAF(V600E) as a biomarker in children with Langerhans cell histiocytosis","volume":"178","author":"Heritier","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E168","DOI":"10.1002\/ajh.26936","article-title":"Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: A prospective clinical trial","volume":"98","author":"Makras","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ajh.26829","article-title":"Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study","volume":"98","author":"Cui","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/bloodadvances.2022009067","article-title":"Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH","volume":"7","author":"Evseev","year":"2023","journal-title":"Blood Adv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12519-021-00487-0","article-title":"Ursodeoxycholic acid prevention on cholestasis associated with total parenteral nutrition in preterm infants: A randomized trial","volume":"18","author":"Liu","year":"2022","journal-title":"World J. Pediatr. WJP"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/clinchem\/hvaa223","article-title":"Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial","volume":"66","author":"Lueong","year":"2020","journal-title":"Clin. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/bjh.16440","article-title":"The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma","volume":"189","author":"Long","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3322\/caac.21650","article-title":"Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions","volume":"71","author":"Cheng","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2023035","DOI":"10.4084\/MJHID.2023.035","article-title":"Expression and Clinical Correlation of PD-1\/PD-L1 and VE1(BRAFp.V600E) in Pediatric Langerhans Cell Histiocytosis","volume":"15","author":"Tandon","year":"2023","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.3324\/haematol.2019.229187","article-title":"Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis","volume":"105","author":"Cui","year":"2020","journal-title":"Haematologica"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/12\/1449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:41:01Z","timestamp":1760114461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/12\/1449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["children11121449"],"URL":"https:\/\/doi.org\/10.3390\/children11121449","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}